Budesonide nasal spray

Generic name
Budesonide nasal spray
Brand name
ATC Code
R01AD05
Compare …

Budesonide nasal spray

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Allergic rhinitis
  • Nasal
    • 6 years up to 18 years
      [1] [2]
      • Initial dose: 256 - 400 microg./day in 1 dose
      • Maintenance dose: The dosage can be halved once a satisfactory effect is achieved 128 - 200 microg./day in 1 dose
      • Directions for administration:

        Spread the dose over both nostrils

      • The minimum effective dose should be used for maintenance treatment

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

Growth retardation: if long-term chronic use of nasal corticosteroids in children is necessary, give as low a dose as possible. Growth retardation in children has been reported with use of therapeutic doses of nasal corticosteroids; monitor height regularly with long-term use, especially with combined inhalation therapy for asthma. If growth inhibition occurs, try to reduce dosage and refer to pediatrician.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Sympathomimetics, plain
R01AA07

References

  1. Euro Registratie Collectief b.v., SmPC Budesonide ERC 32 Nevel (RVG 105052//23837) nov 2023, www.geneesmiddeleninformatiebank.nl
  2. Focus Care Pharmaceuticals B.V., SPC Budesonide 50 mcg (RVG 27395) 12 -06-2019, www.geneesmiddeleninformatiebank.nl

Changes

Therapeutic Drug Monitoring


Overdose